Pulmokine, Inc.
Doing business as Pulmokine
- UEI
- CJAVXCPZUUM9
- CAGE
- 4XMX0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- pulmokine.net
- Founded
- 2007
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A phosphopeptide multiplex PRM mass spectroscopic biomarker assay for PAH | National Heart Lung and Blood Institute | $482,321 | |
| A novel inhaled c-kit/pdgfr inhibitor for the treatment of asthma | National Heart Lung and Blood Institute | $337,324 | |
| Vascular interventions/innovations and therapeutic advances (vita): IND enabling studies for a novel inhaled pdgf… | National Heart Lung and Blood Institute | $1,549,477 | |
| An inhaled dry powder formulation for multi-drug resistant tuberculosis | NIAID DEA OA Acquisitions | $224,960 | |
| An inhaled pdgf receptor inhibitor for the treatment of pulmonary arterial hyper | National Heart Lung and Blood Institute | $5,271,635 |
Quick answers
What is Pulmokine, Inc.'s UEI?
Pulmokine, Inc.'s Unique Entity ID (UEI) in SAM.gov is CJAVXCPZUUM9.
What is Pulmokine, Inc.'s CAGE code?
Pulmokine, Inc.'s CAGE code is 4XMX0.
What is Pulmokine, Inc.'s primary NAICS code?
Pulmokine, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Is Pulmokine, Inc. registered in SAM.gov?
Pulmokine, Inc.'s SAM.gov registration expired on October 5, 2020.
What is Pulmokine, Inc.'s most recent federal award?
Pulmokine, Inc.'s most recent federal grant award is A phosphopeptide multiplex PRM mass spectroscopic biomarker assay for PAH (R43HL135910), from National Heart Lung and Blood Institute, on April 1, 2017.
On GovTribe
See Pulmokine, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors